Cargando…
Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis
BACKGROUND: Vascular endothelial growth factor (VEGF) has neurotrophic activity which is mediated by its main agonist receptor, VEGFR2. Dysregulation of VEGF causes motor neurone degeneration in a mouse model of amyotrophic lateral sclerosis (ALS), and expression of VEGFR2 is reduced in motor neuron...
Autores principales: | Brockington, Alice, Wokke, Beatrijs, Nixon, Hannah, Hartley, Judith, Shaw, Pamela J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868706/ https://www.ncbi.nlm.nih.gov/pubmed/17456229 http://dx.doi.org/10.1186/1471-2350-8-23 |
Ejemplares similares
-
Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS)
por: Cox, Laura E., et al.
Publicado: (2010) -
Roles of Vascular Endothelial Growth Factor in Amyotrophic Lateral Sclerosis
por: Pronto-Laborinho, Ana Catarina, et al.
Publicado: (2014) -
Reply: The role of
DNAJB2
in amyotrophic lateral sclerosis
por: Chen, Han-Jou, et al.
Publicado: (2016) -
Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGF(δ/δ )mouse model of amyotrophic lateral sclerosis
por: Brockington, Alice, et al.
Publicado: (2010) -
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2011)